Prevalence and Severity of Chronic Kidney Disease in Haiti.
Adult
Humans
Female
Male
Haiti
/ epidemiology
Prevalence
Creatinine
Nutrition Surveys
Longitudinal Studies
Cross-Sectional Studies
Glomerular Filtration Rate
Renal Insufficiency, Chronic
/ diagnosis
Diabetes Mellitus
/ epidemiology
Risk Factors
Hypertension
/ epidemiology
Albumins
Albuminuria
/ urine
Journal
Clinical journal of the American Society of Nephrology : CJASN
ISSN: 1555-905X
Titre abrégé: Clin J Am Soc Nephrol
Pays: United States
ID NLM: 101271570
Informations de publication
Date de publication:
01 Jun 2023
01 Jun 2023
Historique:
received:
22
12
2022
accepted:
30
03
2023
pmc-release:
01
06
2024
medline:
12
6
2023
pubmed:
21
4
2023
entrez:
21
04
2023
Statut:
ppublish
Résumé
CKD is a major cause of morbidity and mortality in lower-income countries. However, population-based studies characterizing the epidemiology of CKD in these settings are lacking. The study objective was to describe the epidemiology of CKD in a population-based cohort in urban Haiti, including estimates of the prevalence by CKD stage, the magnitude of associated factors with CKD, and the proportion on guideline-recommended treatment. We assessed the prevalence of CKD and associated risk factors in the population-based Haiti Cardiovascular Disease Cohort. We analyzed cross-sectional data from 2424 adults who completed a clinical examination, risk factor surveys, and laboratory measurements for serum creatinine, urinary albumin, and urinary creatinine. We compared our results with US estimates from the National Health and Nutrition Examination Survey. CKD was defined as either a reduced eGFR <60 ml/min per 1.73 m 2 or urinary albumin-to-creatinine ratio ≥30 mg/g according to the Kidney Disease Improving Global Outcomes guidelines. Multivariable logistic regression identified associated factors with CKD. The mean age was 42 years, 57% of participants were female, and 69% lived in extreme poverty on ≤1 US dollar per day. The age-standardized prevalence of CKD was 14% (95% confidence interval [CI], 12% to 15%). The age-standardized prevalence of reduced eGFR and elevated urinary albumin-to-creatinine ratio was 3% (95% CI, 2% to 4%) and 11% (95% CI, 10% to 13%), respectively. Diabetes (adjusted odds ratio, 4.1; 95% CI, 2.7 to 6.2) and hypertension (adjusted odds ratio, 2.9; 95% CI, 2.0 to 4.2) were significantly associated with CKD. Only 12% of participants with CKD and albuminuria were on guideline-recommended agents, such as angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers. In a large population-based cohort of Haitian adults, CKD was highly associated with both diabetes and hypertension. The proportion of participants with CKD on treatment was low, underscoring the need for strengthening clinical management and nephrology care health infrastructure in Haiti. A Longitudinal Cohort Study to Evaluate Cardiovascular Risk Factors and Disease in Haiti, NCT03892265 .
Sections du résumé
BACKGROUND
BACKGROUND
CKD is a major cause of morbidity and mortality in lower-income countries. However, population-based studies characterizing the epidemiology of CKD in these settings are lacking. The study objective was to describe the epidemiology of CKD in a population-based cohort in urban Haiti, including estimates of the prevalence by CKD stage, the magnitude of associated factors with CKD, and the proportion on guideline-recommended treatment.
METHODS
METHODS
We assessed the prevalence of CKD and associated risk factors in the population-based Haiti Cardiovascular Disease Cohort. We analyzed cross-sectional data from 2424 adults who completed a clinical examination, risk factor surveys, and laboratory measurements for serum creatinine, urinary albumin, and urinary creatinine. We compared our results with US estimates from the National Health and Nutrition Examination Survey. CKD was defined as either a reduced eGFR <60 ml/min per 1.73 m 2 or urinary albumin-to-creatinine ratio ≥30 mg/g according to the Kidney Disease Improving Global Outcomes guidelines. Multivariable logistic regression identified associated factors with CKD.
RESULTS
RESULTS
The mean age was 42 years, 57% of participants were female, and 69% lived in extreme poverty on ≤1 US dollar per day. The age-standardized prevalence of CKD was 14% (95% confidence interval [CI], 12% to 15%). The age-standardized prevalence of reduced eGFR and elevated urinary albumin-to-creatinine ratio was 3% (95% CI, 2% to 4%) and 11% (95% CI, 10% to 13%), respectively. Diabetes (adjusted odds ratio, 4.1; 95% CI, 2.7 to 6.2) and hypertension (adjusted odds ratio, 2.9; 95% CI, 2.0 to 4.2) were significantly associated with CKD. Only 12% of participants with CKD and albuminuria were on guideline-recommended agents, such as angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers.
CONCLUSIONS
CONCLUSIONS
In a large population-based cohort of Haitian adults, CKD was highly associated with both diabetes and hypertension. The proportion of participants with CKD on treatment was low, underscoring the need for strengthening clinical management and nephrology care health infrastructure in Haiti.
CLINICAL TRIAL REGISTRY NAME AND REGISTRATION NUMBER
UNASSIGNED
A Longitudinal Cohort Study to Evaluate Cardiovascular Risk Factors and Disease in Haiti, NCT03892265 .
Identifiants
pubmed: 37081617
doi: 10.2215/CJN.0000000000000175
pii: 01277230-202306000-00010
pmc: PMC10278829
doi:
Substances chimiques
Creatinine
AYI8EX34EU
Albumins
0
Banques de données
ClinicalTrials.gov
['NCT03892265']
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
739-747Informations de copyright
Copyright © 2023 by the American Society of Nephrology.
Références
Tonelli M, Wiebe N, Culleton B, House A, Rabbat C, Fok M. Chronic kidney disease and mortality risk: a systematic review. J Am Soc Nephrol. 2006;17(7):2034–2047. doi: 10.1681/ASN.2005101085
doi: 10.1681/ASN.2005101085
United States Renal Data System. USRDS Annual Data Report: Epidemiology of Kidney Disease in the United States [Internet]. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases; 2020. https://adr.usrds.org/2020
Feldman HI, Appel LJ, Chertow GM, Cifelli D, Cizman B, Daugirdas J. The chronic renal insufficiency cohort (CRIC) study: design and methods. J Am Soc Nephrol. 2003;14(suppl 2):S148–S153. doi: 10.1097/01.ASN.0000070149.78399.ce
doi: 10.1097/01.ASN.0000070149.78399.ce
Brück K, Stel VS, Gambaro G, Hallan S, Völzke H, Ärnlöv J. CKD prevalence varies across the European general population. J Am Soc Nephrol. 2016;27(7):2135–2147. doi: 10.1681/ASN.2015050542
doi: 10.1681/ASN.2015050542
Stanifer JW, Jing B, Tolan S, Helmke N, Mukerjee R, Naicker S. The epidemiology of chronic kidney disease in sub-Saharan Africa: a systematic review and meta-analysis. Lancet Glob Health. 2014;2(3):e174–e181. doi: 10.1016/s2214-109x(14)70002-6
doi: 10.1016/s2214-109x(14)70002-6
Vos T, Lim SS, Abbafati C, Abbas KM, Abbasi M, Abbasifard M. Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet. 2020;396(10258):1204–1222. doi: 10.1016/s0140-6736(20)30925-9
doi: 10.1016/s0140-6736(20)30925-9
Norris KC, Agodoa LY. Unraveling the racial disparities associated with kidney disease. Kidney Int. 2005;68(3):914–924. doi: 10.1111/j.1523-1755.2005.00485.x
doi: 10.1111/j.1523-1755.2005.00485.x
Hsu C, Lin F, Vittinghoff E, Shlipak MG. Racial differences in the progression from chronic renal insufficiency to end-stage renal disease in the United States. J Am Soc Nephrol. 2003;14(11):2902–2907. doi: 10.1097/01.ASN.0000091586.46532.b4
doi: 10.1097/01.ASN.0000091586.46532.b4
Assari S. Racial disparities in chronic kidney diseases in the United States; a pressing public health challenge with social, behavioral and medical causes. J Nephropharmacol. 2016;5(1):4–6. PMID: 28197489
Tonelli M, Dickinson JA. Early detection of CKD: implications for low-income, middle-income, and high-income countries. J Am Soc Nephrol. 2020;31(9):1931–1940. doi: 10.1681/ASN.2020030277
doi: 10.1681/ASN.2020030277
Baptiste D-L, Hamilton JB, Foronda C, Sloand E, Fahlberg B, Pfaff T. Hypertension among adults living in Haiti: an integrative review. J Clin Nurs. 2018;27(13-14):2536–2545. doi: 10.1111/jocn.14320
doi: 10.1111/jocn.14320
Metz M, Pierre JL, Yan LD, Rouzier V, St-Preux S, Exantus S. Hypertension continuum of care: blood pressure screening, diagnosis, treatment, and control in a population-based cohort in Haiti. J Clin Hypertens. 2022;24(3):246–254. doi: 10.1111/jch.14399
doi: 10.1111/jch.14399
Tymejczyk O, McNairy ML, Petion JS, Rivera VR, Dorélien A, Peck M. Hypertension prevalence and risk factors among residents of four slum communities: population-representative findings from Port-au-Prince, Haiti. J Hypertens. 2019;37(4):685–695. doi: 10.1097/hjh.0000000000001966
doi: 10.1097/hjh.0000000000001966
Yan LD, McNairy ML, Dévieux JG, Pierre JL, Dade E, Sufra R. Neighborhood cohesion and violence in Port-au-Prince, Haiti, and their relationship to stress, depression, and hypertension: findings from the Haiti cardiovascular disease cohort study. PLOS Glob Public Health. 2022;2(7):e0000503. doi: 10.1371/journal.pgph.0000503
doi: 10.1371/journal.pgph.0000503
Dade E, Metz M, Pierre JL, Rouzier V, Sufra R, Fox E. High prevalence of obesity among women in urban Haiti: findings from a population-based cohort. Front Public Health. 2022;10:976909. doi: 10.3389/fpubh.2022.976909
doi: 10.3389/fpubh.2022.976909
Bello AK, Levin A, Lunney M, Osman MA, Ye F, Ashuntantang GE. Status of care for end stage kidney disease in countries and regions worldwide: international cross sectional survey. BMJ. 2019;367:l5873. doi: 10.1136/bmj.l5873
doi: 10.1136/bmj.l5873
Exantus J. Global dialysis perspective: Haiti. Kidney360. 2022;3(6):1105–1108. doi: 10.34067/kid.0007592021
doi: 10.34067/kid.0007592021
Lookens J, Tymejczyk O, Rouzier V, Smith C, Preval F, Joseph I. The Haiti cardiovascular disease cohort: study protocol for a population-based longitudinal cohort. BMC Public Health. 2020;20(1):1633. doi: 10.1186/s12889-020-09734-x
doi: 10.1186/s12889-020-09734-x
UNData. Haiti | Country Profile. http://data.un.org/en/iso/ht.html
World Health Organization. WHO STEPS Surveillance Manual: The WHO STEPwise Approach to Chronic Disease Risk Factor Surveillance. WHO; 2017.
Whelton PK, Carey RM, Aronow WS, Casey DE, Collins KJ, Dennison Himmelfarb C. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol. 2018;71(19):e127–e248. doi: 10.1016/j.jacc.2017.11.006
doi: 10.1016/j.jacc.2017.11.006
Moore JF, Sharer JD. Methods for quantitative creatinine determination. Curr Protoc Hum Genet. 2017;93(1):A.3O.1–A.3O.7. doi: 10.1002/cphg.38
doi: 10.1002/cphg.38
Inker LA, Eneanya ND, Coresh J, Tighiouart H, Wang D, Sang Y. New creatinine- and Cystatin C–based equations to estimate GFR without race. N Engl J Med. 2021;385(19):1737–1749. doi: 10.1056/nejmoa2102953
doi: 10.1056/nejmoa2102953
KDIGO CKD Work Group. KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int Suppl. 2013;3(1):136–150. doi: 10.1038/kisup.2012.73
doi: 10.1038/kisup.2012.73
Manne-Goehler J, Geldsetzer P, Agoudavi K, Andall-Brereton G, Aryal KK, Bicaba BW. Health system performance for people with diabetes in 28 low- and middle-income countries: a cross-sectional study of nationally representative surveys. PLos Med. 2019;16(3):e1002751. doi: 10.1371/journal.pmed.1002751
doi: 10.1371/journal.pmed.1002751
National Center for Health Statistics. NHANES Questionnaires, Datasets, and Related Documentation. Centers for Disease Control and Prevention, 2020.
National Cancer Institute. Standard Populations—Single Ages. https://seer.cancer.gov/stdpopulations/stdpop.singleages.html
Shlipak MG, Tummalapalli SL, Boulware LE, Grams ME, Ix JH, Jha V. The case for early identification and intervention of chronic kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference. Kidney Int. 2021;99(1):34–47. doi: 10.1016/j.kint.2020.10.012
doi: 10.1016/j.kint.2020.10.012
DeGennaro V Jr, Malcolm S, Crompton L, Vaddiparti K, Mramba LK, Striley C. Community-based diagnosis of non-communicable diseases and their risk factors in rural and urban Haiti: a cross-sectional prevalence study. BMJ Open. 2018;8(4):e020317. doi: 10.1136/bmjopen-2017-020317
doi: 10.1136/bmjopen-2017-020317
Kaze AD, Ilori T, Jaar BG, Echouffo-Tcheugui JB. Burden of chronic kidney disease on the African continent: a systematic review and meta-analysis. BMC Nephrol. 2018;19(1):125. doi: 10.1186/s12882-018-0930-5
doi: 10.1186/s12882-018-0930-5
Couser WG, Remuzzi G, Mendis S, Tonelli M. The contribution of chronic kidney disease to the global burden of major noncommunicable diseases. Kidney Int. 2011;80(12):1258–1270. doi: 10.1038/ki.2011.368
doi: 10.1038/ki.2011.368
World Health Organization. WHO Model List of Essential Medicines—22nd List. 2021.
Xie X, Liu Y, Perkovic V, Li X, Ninomiya T, Hou W. Renin-angiotensin system inhibitors and kidney and cardiovascular outcomes in patients with CKD: a Bayesian network meta-analysis of randomized clinical trials. Am J Kidney Dis. 2016;67(5):728–741. doi: 10.1053/j.ajkd.2015.10.011
doi: 10.1053/j.ajkd.2015.10.011
White SL, Yu R, Craig JC, Polkinghorne KR, Atkins RC, Chadban SJ. Diagnostic accuracy of urine dipsticks for detection of albuminuria in the general community. Am J Kidney Dis. 2011;58(1):19–28. doi: 10.1053/j.ajkd.2010.12.026
doi: 10.1053/j.ajkd.2010.12.026
Liyanage T, Ninomiya T, Jha V, Neal B, Patrice HM, Okpechi I. Worldwide access to treatment for end-stage kidney disease: a systematic review. Lancet. 2015;385(9981):1975–1982. doi: 10.1016/s0140-6736(14)61601-9
doi: 10.1016/s0140-6736(14)61601-9
Jeudy JM, Ciancio G. Haiti’s kidney transplantation unit. Lancet. 2021;397(10278):970. doi: 10.1016/s0140-6736(21)00353-6
doi: 10.1016/s0140-6736(21)00353-6
Fabian J, Kalyesubula R, Mkandawire J, Hansen CH, Nitsch D, Musenge E. Measurement of kidney function in Malawi, South Africa, and Uganda: a multicentre cohort study. Lancet Glob Health. 2022;10(8):e1159–e1169. doi: 10.1016/s2214-109x(22)00239-x
doi: 10.1016/s2214-109x(22)00239-x